Boyages Steven Constantine 4

What Happened

• Steven Boyages, a director of Intelligent Bio Solutions, was granted 5,000 restricted shares of common stock on March 18, 2026 (transaction code A — award/grant). The shares were granted at $0.00 (no cash paid) and are subject to forfeiture until vested, with time-based vesting after 12 months. This is a compensation award rather than an open‑market purchase or sale.

Key Details

• Transaction date: March 18, 2026; Form 4 filed March 20, 2026 (timely filing).
• Security: 5,000 restricted shares of common stock; acquisition price reported $0.00.
• Vesting: Time-based vesting after 12 months; shares are forfeitable until vested (per footnote).
• Post‑reverse split reporting: All amounts are presented post a 1‑for‑10 reverse stock split effective Dec 15, 2025 (footnote).
• Shares owned after the transaction: Not specified in the provided filing summary.
• Filing status: Appears timely (filed within two business days of the transaction).

Context

• Grants of restricted stock to directors are common as compensation and do not, by themselves, indicate a purchase-based bullish signal or a sale-based bearish signal; they reflect equity compensation and retention practices. The award was made under the company's 2019 Long Term Incentive Plan and vests over time per the footnote.